The Nutshell

» ecology, cell & molecular biology and disease/medicine

Daily News Roundup

Most Recent

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

1 Comment

The dolphins and their trainers will search for the endangered porpoises and enclose them in a protected pen.

0 Comments

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Researchers use base-editing to swap out an erroneous nucleotide responsible for a potentially life-threatening blood disorder.

0 Comments

image: Enormous University Gift Raises Questions over Donor Influence

Enormous University Gift Raises Questions over Donor Influence

By | September 26, 2017

The donation to the University of California, Irvine, is slated to fund a new college focusing on what some critics call pseudoscience and quackery.

9 Comments

Researchers recommend greater conservation efforts toward non-mammals and small creatures.

0 Comments

image: Second Chance for Lost Galapagos Tortoises?

Second Chance for Lost Galapagos Tortoises?

By | September 14, 2017

Researchers are trying to recreate an extinct species of the lumbering reptiles by breeding closely related species that contain traces of the lost lineage’s DNA.

0 Comments

image: How Exercise Might Fight Cancer

How Exercise Might Fight Cancer

By | September 8, 2017

Epinephrine’s activation of the signaling pathway Hippo is responsible for the in vitro tumor-fighting effects of serum from women who worked out.

0 Comments

image: Researchers Advised to Remove Climate Change Language

Researchers Advised to Remove Climate Change Language

By | August 29, 2017

The Department of Energy requested that scientists reword grant proposals to be more in line with the White House’s agenda on climate research.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech